AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2016
Jul 12, 2016
34570_dirs_2016-07-12_734afe34-955d-4344-b988-31731f186908.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-07-08
Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-08 | Common Stock | S | 21190 | $1.8 | Disposed | 4965856 | Direct |
| 2016-07-11 | Common Stock | S | 800 | $1.8 | Disposed | 4965056 | Direct |
More from Actinium Pharmaceuticals, Inc.
Delisting Announcement
2026
May 29
Annual Report
2026
Mar 30
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 26
Board/Management Information
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8